Selected research
Market Outlook & Growth Opportunities
Global Multiplex Molecular Diagnosis Technology Market Outlook and Growth Opportunities 2026
Market perspective
The global Multiplex Molecular Diagnosis Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Multiplex Molecular Diagnosis Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Multiplex Molecular Diagnosis Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Multiplex Molecular Diagnosis Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Multiplex Molecular Diagnosis Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Multiplex Molecular Diagnosis Technology market include Siemens, Hologic, Thermo Fisher Scientific, Koninklijke Philips N.V., NeuroLogica, Shimadzu Medical, GENERAL ELECTRIC, Sysmex and Canon, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Multiplex Molecular Diagnosis Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Multiplex Molecular Diagnosis Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Multiplex Molecular Diagnosis Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Multiplex Molecular Diagnosis Technology market.
Multiplex Molecular Diagnosis Technology Segment by Company
Siemens
Hologic
Thermo Fisher Scientific
Koninklijke Philips N.V.
NeuroLogica
Shimadzu Medical
GENERAL ELECTRIC
Sysmex
Canon
FUJIFILM Holdings
Bio-Rad Laboratories
Roche Diagnostics
Luminex Corporation
Abbott Laboratories
QIAGEN
Multiplex Molecular Diagnosis Technology Segment by Type
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low Density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Multiplex Molecular Diagnosis Technology Segment by Application
Hospital
Outpatient Surgery Centre
Others
Multiplex Molecular Diagnosis Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Multiplex Molecular Diagnosis Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Multiplex Molecular Diagnosis Technology key companies, revenue, market share, and recent developments.
3. To split the Multiplex Molecular Diagnosis Technology breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Multiplex Molecular Diagnosis Technology market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Multiplex Molecular Diagnosis Technology significant trends, drivers, influence factors in global and regions.
6. To analyze Multiplex Molecular Diagnosis Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multiplex Molecular Diagnosis Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Multiplex Molecular Diagnosis Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multiplex Molecular Diagnosis Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Multiplex Molecular Diagnosis Technology industry.
Chapter 3: Detailed analysis of Multiplex Molecular Diagnosis Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Multiplex Molecular Diagnosis Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Multiplex Molecular Diagnosis Technology in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Multiplex Molecular Diagnosis Technology Industry Trends
Table 2. Multiplex Molecular Diagnosis Technology Industry Drivers
Table 3. Multiplex Molecular Diagnosis Technology Industry Opportunities and Challenges
Table 4. Multiplex Molecular Diagnosis Technology Industry Restraints
Table 5. Global Multiplex Molecular Diagnosis Technology Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Multiplex Molecular Diagnosis Technology Revenue Share by Company (2021-2026)
Table 7. Global Multiplex Molecular Diagnosis Technology Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Multiplex Molecular Diagnosis Technology Key Company Manufacturing Base & Headquarters
Table 9. Global Multiplex Molecular Diagnosis Technology Company, Product Type & Application
Table 10. Global Multiplex Molecular Diagnosis Technology Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Multiplex Molecular Diagnosis Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Real-time PCR
Table 15. Significant Companies of Nested PCR with Melt Curve Analysis
Table 16. Significant Companies of PCR with Low Density Microarray
Table 17. Significant Companies of PCR with Liquid Phase Bead Array
Table 18. Significant Companies of PCR with Electrochemical Detection
Table 19. Global Multiplex Molecular Diagnosis Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 20. Global Multiplex Molecular Diagnosis Technology Sales Value by Type (2021-2026) & (US$ Million)
Table 21. Global Multiplex Molecular Diagnosis Technology Sales Value by Type (2027-2032) & (US$ Million)
Table 22. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Type (2021-2026)
Table 23. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Type (2027-2032)
Table 24. Significant Companies of Hospital
Table 25. Significant Companies of Outpatient Surgery Centre
Table 26. Significant Companies of Others
Table 27. Global Multiplex Molecular Diagnosis Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global Multiplex Molecular Diagnosis Technology Sales Value by Application (2021-2026) & (US$ Million)
Table 29. Global Multiplex Molecular Diagnosis Technology Sales Value by Application (2027-2032) & (US$ Million)
Table 30. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Application (2021-2026)
Table 31. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Application (2027-2032)
Table 32. Global Multiplex Molecular Diagnosis Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global Multiplex Molecular Diagnosis Technology Sales Value by Region (2021-2026) & (US$ Million)
Table 34. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Region (2021-2026)
Table 35. Global Multiplex Molecular Diagnosis Technology Sales Value by Region (2027-2032) & (US$ Million)
Table 36. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Region (2027-2032)
Table 37. Global Multiplex Molecular Diagnosis Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global Multiplex Molecular Diagnosis Technology Sales Value by Country (2021-2026) & (US$ Million)
Table 39. Global Multiplex Molecular Diagnosis Technology Sales Value Market Share by Country (2021-2026)
Table 40. Global Multiplex Molecular Diagnosis Technology Sales Value by Country (2027-2032) & (US$ Million)
Table 41. Global Multiplex Molecular Diagnosis Technology Sales Value Market Share by Country (2027-2032)
Table 42. Siemens Company Information
Table 43. Siemens Business Overview
Table 44. Siemens Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 45. Siemens Multiplex Molecular Diagnosis Technology Product Portfolio
Table 46. Siemens Recent Development
Table 47. Hologic Company Information
Table 48. Hologic Business Overview
Table 49. Hologic Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. Hologic Multiplex Molecular Diagnosis Technology Product Portfolio
Table 51. Hologic Recent Development
Table 52. Thermo Fisher Scientific Company Information
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 55. Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Product Portfolio
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Koninklijke Philips N.V. Company Information
Table 58. Koninklijke Philips N.V. Business Overview
Table 59. Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 60. Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Product Portfolio
Table 61. Koninklijke Philips N.V. Recent Development
Table 62. NeuroLogica Company Information
Table 63. NeuroLogica Business Overview
Table 64. NeuroLogica Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. NeuroLogica Multiplex Molecular Diagnosis Technology Product Portfolio
Table 66. NeuroLogica Recent Development
Table 67. Shimadzu Medical Company Information
Table 68. Shimadzu Medical Business Overview
Table 69. Shimadzu Medical Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 70. Shimadzu Medical Multiplex Molecular Diagnosis Technology Product Portfolio
Table 71. Shimadzu Medical Recent Development
Table 72. GENERAL ELECTRIC Company Information
Table 73. GENERAL ELECTRIC Business Overview
Table 74. GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 75. GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Product Portfolio
Table 76. GENERAL ELECTRIC Recent Development
Table 77. Sysmex Company Information
Table 78. Sysmex Business Overview
Table 79. Sysmex Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Sysmex Multiplex Molecular Diagnosis Technology Product Portfolio
Table 81. Sysmex Recent Development
Table 82. Canon Company Information
Table 83. Canon Business Overview
Table 84. Canon Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 85. Canon Multiplex Molecular Diagnosis Technology Product Portfolio
Table 86. Canon Recent Development
Table 87. FUJIFILM Holdings Company Information
Table 88. FUJIFILM Holdings Business Overview
Table 89. FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 90. FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Product Portfolio
Table 91. FUJIFILM Holdings Recent Development
Table 92. Bio-Rad Laboratories Company Information
Table 93. Bio-Rad Laboratories Business Overview
Table 94. Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 95. Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
Table 96. Bio-Rad Laboratories Recent Development
Table 97. Roche Diagnostics Company Information
Table 98. Roche Diagnostics Business Overview
Table 99. Roche Diagnostics Multiplex Molecular Diagnosis Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 100. Roche Diagnostics Multiplex Molecular Diagnosis Technology Product Portfolio
Table 101. Roche Diagnostics Recent Development
Table 102. Luminex Corporation Company Information
Table 103. Luminex Corporation Business Overview
Table 104. Luminex Corporation Multiplex Molecular Diagnosis Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 105. Luminex Corporation Multiplex Molecular Diagnosis Technology Product Portfolio
Table 106. Luminex Corporation Recent Development
Table 107. Abbott Laboratories Company Information
Table 108. Abbott Laboratories Business Overview
Table 109. Abbott Laboratories Multiplex Molecular Diagnosis Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 110. Abbott Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
Table 111. Abbott Laboratories Recent Development
Table 112. QIAGEN Company Information
Table 113. QIAGEN Business Overview
Table 114. QIAGEN Multiplex Molecular Diagnosis Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 115. QIAGEN Multiplex Molecular Diagnosis Technology Product Portfolio
Table 116. QIAGEN Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Authors List of This Report
Table 119. Secondary Sources
Table 120. Primary Sources
List of Figures
Figure 1. Multiplex Molecular Diagnosis Technology Product Image
Figure 2. Global Multiplex Molecular Diagnosis Technology Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Multiplex Molecular Diagnosis Technology Market Size (2021-2032) & (US$ Million)
Figure 4. Global Multiplex Molecular Diagnosis Technology Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Real-time PCR Image
Figure 8. Nested PCR with Melt Curve Analysis Image
Figure 9. PCR with Low Density Microarray Image
Figure 10. PCR with Liquid Phase Bead Array Image
Figure 11. PCR with Electrochemical Detection Image
Figure 12. Global Multiplex Molecular Diagnosis Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Multiplex Molecular Diagnosis Technology Sales Value Share 2021 VS 2025 VS 2032
Figure 14. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Type (2021-2032)
Figure 15. Hospital Image
Figure 16. Outpatient Surgery Centre Image
Figure 17. Others Image
Figure 18. Global Multiplex Molecular Diagnosis Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Multiplex Molecular Diagnosis Technology Sales Value Share 2021 VS 2025 VS 2032
Figure 20. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Application (2021-2032)
Figure 21. Global Multiplex Molecular Diagnosis Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 22. Global Multiplex Molecular Diagnosis Technology Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 23. North America Multiplex Molecular Diagnosis Technology Sales Value (2021-2032) & (US$ Million)
Figure 24. North America Multiplex Molecular Diagnosis Technology Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Europe Multiplex Molecular Diagnosis Technology Sales Value (2021-2032) & (US$ Million)
Figure 26. Europe Multiplex Molecular Diagnosis Technology Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Asia-Pacific Multiplex Molecular Diagnosis Technology Sales Value (2021-2032) & (US$ Million)
Figure 28. Asia-Pacific Multiplex Molecular Diagnosis Technology Sales Value Share by Country (%), 2025 VS 2032
Figure 29. South America Multiplex Molecular Diagnosis Technology Sales Value (2021-2032) & (US$ Million)
Figure 30. South America Multiplex Molecular Diagnosis Technology Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Middle East & Africa Multiplex Molecular Diagnosis Technology Sales Value (2021-2032) & (US$ Million)
Figure 32. Middle East & Africa Multiplex Molecular Diagnosis Technology Sales Value Share by Country (%), 2025 VS 2032
Figure 33. USA Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. USA Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. USA Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Canada Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Canada Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Canada Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Mexico Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Mexico Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Mexico Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Germany Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Germany Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Germany Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. France Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. France Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. France Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. U.K. Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. U.K. Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. U.K. Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Italy Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Italy Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Italy Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Spain Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Spain Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Spain Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Russia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Russia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Russia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Netherlands Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Netherlands Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Netherlands Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Nordic Countries Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Nordic Countries Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. China Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. China Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. China Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Japan Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Japan Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Japan Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. South Korea Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. South Korea Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. South Korea Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. India Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. India Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. India Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Australia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Australia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Australia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Southeast Asia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Southeast Asia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Brazil Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Brazil Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Brazil Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Argentina Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Argentina Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Argentina Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Chile Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Chile Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Chile Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Colombia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Colombia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Colombia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Peru Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Peru Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Peru Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Saudi Arabia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Israel Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Israel Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Israel Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. UAE Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. UAE Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. UAE Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Turkey Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Turkey Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Turkey Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Iran Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Iran Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Iran Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Egypt Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Egypt Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Egypt Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Years Considered
Figure 118. Research Process
Figure 119. Key Executives Interviewed
Scope & coverage.
Types
- Real-time PCR
- Nested PCR with Melt Curve Analysis
- PCR with Low Density Microarray
- PCR with Liquid Phase Bead Array
- PCR with Electrochemical Detection
Applications
- Hospital
- Outpatient Surgery Centre
- Others
Companies covered
- Siemens
- Hologic
- Thermo Fisher Scientific
- Koninklijke Philips N.V.
- NeuroLogica
- Shimadzu Medical
- GENERAL ELECTRIC
- Sysmex
- Canon
- FUJIFILM Holdings
- Bio-Rad Laboratories
- Roche Diagnostics
- Luminex Corporation
- Abbott Laboratories
- QIAGEN
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Multiplex Molecular Diagnosis Technology Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Multiplex Molecular Diagnosis Technology Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Multiplex Molecular Diagnosis Technology Market Dynamics
- 2.1 Multiplex Molecular Diagnosis Technology Industry Trends
- 2.2 Multiplex Molecular Diagnosis Technology Industry Drivers
- 2.3 Multiplex Molecular Diagnosis Technology Industry Opportunities and Challenges
- 2.4 Multiplex Molecular Diagnosis Technology Industry Restraints
3 Multiplex Molecular Diagnosis Technology Market by Company
- 3.1 Global Multiplex Molecular Diagnosis Technology Company Revenue Ranking in 2025
- 3.2 Global Multiplex Molecular Diagnosis Technology Revenue by Company (2021-2026)
- 3.3 Global Multiplex Molecular Diagnosis Technology Company Ranking (2024-2026)
- 3.4 Global Multiplex Molecular Diagnosis Technology Company Manufacturing Base and Headquarters
- 3.5 Global Multiplex Molecular Diagnosis Technology Company Product Type and Application
- 3.6 Global Multiplex Molecular Diagnosis Technology Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Multiplex Molecular Diagnosis Technology Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Multiplex Molecular Diagnosis Technology Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Multiplex Molecular Diagnosis Technology Market by Type
- 4.1 Multiplex Molecular Diagnosis Technology Type Introduction
- 4.1.1 Real-time PCR
- 4.1.2 Nested PCR with Melt Curve Analysis
- 4.1.3 PCR with Low Density Microarray
- 4.1.4 PCR with Liquid Phase Bead Array
- 4.1.5 PCR with Electrochemical Detection
- 4.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Type
- 4.2.1 Global Multiplex Molecular Diagnosis Technology Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Type (2021-2032)
- 4.2.3 Global Multiplex Molecular Diagnosis Technology Sales Value Share by Type (2021-2032)
5 Multiplex Molecular Diagnosis Technology Market by Application
- 5.1 Multiplex Molecular Diagnosis Technology Application Introduction
- 5.1.1 Hospital
- 5.1.2 Outpatient Surgery Centre
- 5.1.3 Others
- 5.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Application
- 5.2.1 Global Multiplex Molecular Diagnosis Technology Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Application (2021-2032)
- 5.2.3 Global Multiplex Molecular Diagnosis Technology Sales Value Share by Application (2021-2032)
6 Multiplex Molecular Diagnosis Technology Regional Value Analysis
- 6.1 Global Multiplex Molecular Diagnosis Technology Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Region (2021-2032)
- 6.2.1 Global Multiplex Molecular Diagnosis Technology Sales Value by Region: 2021-2026
- 6.2.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Multiplex Molecular Diagnosis Technology Sales Value (2021-2032)
- 6.3.2 North America Multiplex Molecular Diagnosis Technology Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Multiplex Molecular Diagnosis Technology Sales Value (2021-2032)
- 6.4.2 Europe Multiplex Molecular Diagnosis Technology Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Multiplex Molecular Diagnosis Technology Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Multiplex Molecular Diagnosis Technology Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Multiplex Molecular Diagnosis Technology Sales Value (2021-2032)
- 6.6.2 South America Multiplex Molecular Diagnosis Technology Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Multiplex Molecular Diagnosis Technology Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Multiplex Molecular Diagnosis Technology Sales Value Share by Country, 2025 VS 2032
7 Multiplex Molecular Diagnosis Technology Country-level Value Analysis
- 7.1 Global Multiplex Molecular Diagnosis Technology Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Country (2021-2032)
- 7.2.1 Global Multiplex Molecular Diagnosis Technology Sales Value by Country (2021-2026)
- 7.2.2 Global Multiplex Molecular Diagnosis Technology Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.7.2 France Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.14.2 China Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.17.2 India Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Multiplex Molecular Diagnosis Technology Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Multiplex Molecular Diagnosis Technology Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Multiplex Molecular Diagnosis Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Siemens
- 8.1.1 Siemens Company Information
- 8.1.2 Siemens Business Overview
- 8.1.3 Siemens Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.1.4 Siemens Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.1.5 Siemens Recent Developments
- 8.2 Hologic
- 8.2.1 Hologic Company Information
- 8.2.2 Hologic Business Overview
- 8.2.3 Hologic Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.2.4 Hologic Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.2.5 Hologic Recent Developments
- 8.3 Thermo Fisher Scientific
- 8.3.1 Thermo Fisher Scientific Company Information
- 8.3.2 Thermo Fisher Scientific Business Overview
- 8.3.3 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.3.4 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.3.5 Thermo Fisher Scientific Recent Developments
- 8.4 Koninklijke Philips N.V.
- 8.4.1 Koninklijke Philips N.V. Company Information
- 8.4.2 Koninklijke Philips N.V. Business Overview
- 8.4.3 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.4.4 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.4.5 Koninklijke Philips N.V. Recent Developments
- 8.5 NeuroLogica
- 8.5.1 NeuroLogica Company Information
- 8.5.2 NeuroLogica Business Overview
- 8.5.3 NeuroLogica Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.5.4 NeuroLogica Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.5.5 NeuroLogica Recent Developments
- 8.6 Shimadzu Medical
- 8.6.1 Shimadzu Medical Company Information
- 8.6.2 Shimadzu Medical Business Overview
- 8.6.3 Shimadzu Medical Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.6.4 Shimadzu Medical Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.6.5 Shimadzu Medical Recent Developments
- 8.7 GENERAL ELECTRIC
- 8.7.1 GENERAL ELECTRIC Company Information
- 8.7.2 GENERAL ELECTRIC Business Overview
- 8.7.3 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.7.4 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.7.5 GENERAL ELECTRIC Recent Developments
- 8.8 Sysmex
- 8.8.1 Sysmex Company Information
- 8.8.2 Sysmex Business Overview
- 8.8.3 Sysmex Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.8.4 Sysmex Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.8.5 Sysmex Recent Developments
- 8.9 Canon
- 8.9.1 Canon Company Information
- 8.9.2 Canon Business Overview
- 8.9.3 Canon Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.9.4 Canon Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.9.5 Canon Recent Developments
- 8.10 FUJIFILM Holdings
- 8.10.1 FUJIFILM Holdings Company Information
- 8.10.2 FUJIFILM Holdings Business Overview
- 8.10.3 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.10.4 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.10.5 FUJIFILM Holdings Recent Developments
- 8.11 Bio-Rad Laboratories
- 8.11.1 Bio-Rad Laboratories Company Information
- 8.11.2 Bio-Rad Laboratories Business Overview
- 8.11.3 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.11.4 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.11.5 Bio-Rad Laboratories Recent Developments
- 8.12 Roche Diagnostics
- 8.12.1 Roche Diagnostics Company Information
- 8.12.2 Roche Diagnostics Business Overview
- 8.12.3 Roche Diagnostics Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.12.4 Roche Diagnostics Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.12.5 Roche Diagnostics Recent Developments
- 8.13 Luminex Corporation
- 8.13.1 Luminex Corporation Company Information
- 8.13.2 Luminex Corporation Business Overview
- 8.13.3 Luminex Corporation Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.13.4 Luminex Corporation Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.13.5 Luminex Corporation Recent Developments
- 8.14 Abbott Laboratories
- 8.14.1 Abbott Laboratories Company Information
- 8.14.2 Abbott Laboratories Business Overview
- 8.14.3 Abbott Laboratories Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.14.4 Abbott Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.14.5 Abbott Laboratories Recent Developments
- 8.15 QIAGEN
- 8.15.1 QIAGEN Company Information
- 8.15.2 QIAGEN Business Overview
- 8.15.3 QIAGEN Multiplex Molecular Diagnosis Technology Revenue and Gross Margin (2021-2026)
- 8.15.4 QIAGEN Multiplex Molecular Diagnosis Technology Product Portfolio
- 8.15.5 QIAGEN Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst